An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream Infections - Trial NCT06211829
Access comprehensive clinical trial information for NCT06211829 through Pure Global AI's free database. This phase not specified trial is sponsored by Methodist Health System and is currently Recruitment Completed. The study focuses on Bacterial Infections. Target enrollment is 208 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Methodist Health System
Timeline & Enrollment
N/A
May 18, 2022
May 18, 2024
Primary Outcome
number of Staphylococcus Aureus blood stream infections (SAB)
Summary
In July 2020, a bundle (Appendix C) was implemented at Methodist Dallas Medical Center where
 all patients with SAB were reviewed by the antimicrobial stewardship pharmacist (Monday -
 Friday from 0700 to 1500), a note outlining optimal interventions was written in the
 electronic medical record (EMR), and the recommendations were communicated to the primary
 team via secure messaging or telephone
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06211829
Non-Device Trial